Tafluprost ophthalmic solution 0.0015%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tafluprost ophthalmic solution 0.0015%, covering 2015-05-14 to 2015-05-14. Get the full timeline:
Most recent: Clinical Trial Update: DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5% [Phase 3]